Showing all 33 results

2020 FDA Approvals Ado-trastuzumab-emtansine
+
 Quick View

anti-human

Ado-trastuzumab emtansine Biosimilar – Research Grade [ICH4014]

$1,144.00 – $7,500.00
Western Blot of Atezolizumab Biosimilar ICH4018
+
 Quick View

anti-human

Atezolizumab Biosimilar – Research Grade [ICH4018]

$718.00 – $7,500.00
Western Blot of Adalimumab Biosimilar ICH40012020 FDA Approvals Adalimumab
+
 Quick View

anti-human

Adalimumab Biosimilar – Research Grade

$718.00 – $7,500.00
2020 FDA Approvals for Ranibizumab
+
 Quick View

anti-human

Ranibizumab Biosimilar – Research Grade [ICH4031]

$300.00 – $7,500.00
2020 FDA Approvals for Rituximab
+
 Quick View

anti-human

Rituximab Biosimilar – Research Grade [ICH4011]

$718.00 – $7,500.00
2020 FDA Approvals for Pertuzumab
+
 Quick View

anti-human

Pertuzumab Biosimilar – Research Grade [ICH4030]

$718.00 – $7,500.00
Western Blot of Pembrolizumab Biosimilar ICH40292020 FDA Approvals for Pembrolizumab
+
 Quick View

anti-human

Pembrolizumab Biosimilar – Research Grade [ICH4029]

$718.00 – $7,500.00
2020 FDA Approvals Ipilimumab
+
 Quick View

anti-human

Ipilimumab Biosimilar – Research Grade [ICH4025]

$718.00 – $7,500.00
2020 FDA Approvals for Alemtuzumab
+
 Quick View

Antibodies

Alemtuzumab Biosimilar – Research Grade [ICH4002]

$718.00 – $7,500.00
Natalizumab biosimilar
+
 Quick View

anti-human

Natalizumab Biosimilar – Research Grade [ICH4037]

$704.00 – $7,500.00
+
 Quick View

anti-human

Etanercept Biosimilar – Research Grade [ICH4022]

$718.00 – $7,500.00
2020 FDA Approvals Bevacizumab
+
 Quick View

anti-human

Bevacizumab Biosimilar – Research Grade [ICH4003]

$718.00 – $7,500.00
2020 FDA Approvals for Trastuzumab
+
 Quick View

anti-human

Trastuzumab Biosimilar – Research Grade [ICH4013]

$718.00 – $7,500.00
2020 FDA Approvals Denosumab
+
 Quick View

anti-human

Denosumab Biosimilar – Research Grade [ICH4019]

$718.00 – $7,500.00
Western Blot of Avelumab Biosimilar ICH40172020 FDA Approvals Avelumab
+
 Quick View

anti-human

Avelumab Biosimilar – Research Grade [ICH4017]

$718.00 – $7,500.00
2020 FDA Approvals for Ustekinumab
+
 Quick View

anti-human

Ustekinumab Biosimilar – Research Grade [ICH4034]

$718.00 – $7,500.00
2020 FDA Approvals for Ofatumumab
+
 Quick View

anti-human

Ofatumumab Biosimilar – Research Grade [ICH4027]

$718.00 – $7,500.00
2020 FDA Approvals for Nivolumab
+
 Quick View

anti-human

Nivolumab Biosimilar – Research Grade [ICH4009]

$718.00 – $7,500.00
2020 FDA Approvals Alirocumab
+
 Quick View

anti-human

Alirocumab Biosimilar – Research Grade [ICH4016]

$718.00 – $15,000.00
2020 FDA Approvals for Vedolizumab
+
 Quick View

anti-human

Vedolizumab Biosimilar – Research Grade [ICH4035]

$718.00 – $7,500.00
2020 FDA Approvals for Tocilizumab
+
 Quick View

anti-human

Tocilizumab Biosimilar – Research Grade [ICH4012]

$936.00 – $7,500.00
2020 FDA Approvals Cetuximab
+
 Quick View

anti-human

Cetuximab Biosimilar – Research Grade [ICH4004]

$718.00 – $7,500.00
+
 Quick View

Antibodies

Daratumumab Biosimilar – Research Grade [ICH4020]

$500.00 – $10,404.00
Western Blot of Durvalumab Biosimilar ICH5005
+
 Quick View

anti-human

Durvalumab Biosimilar – Research Grade [ICH5005]

$718.00 – $7,500.00
Western Blot of Tislelizumab Biosimilar ICH5004
+
 Quick View

anti-human

Tislelizumab Biosimilar – Research Grade [ICH5004]

$718.00 – $7,500.00
+
 Quick View

anti-human

Camrelizumab Biosimilar – Research Grade [ICH5003]

$718.00 – $7,500.00
Western Blot of Toripalimab Biosimilar ICH5002
+
 Quick View

anti-human

Toripalimab Biosimilar – Research Grade [ICH5002]

$718.00 – $7,500.00
Western Blot of Sintilimab Biosimilar ICH5001
+
 Quick View

anti-human

Sintilimab Biosimilar – Research Grade [ICH5001]

$718.00 – $7,500.00
+
 Quick View

anti-human

Mepolizumab Biosimilar – Research Grade [ICH4036]

$718.00 – $7,500.00
FDA Approvals for Omalizumab
+
 Quick View

anti-human

Omalizumab Biosimilar – Research Grade [ICH4010]

$718.00 – $7,500.00
+
 Quick View

anti-human

Nimotuzumab Biosimilar – Research Grade [ICH4008]

$718.00 – $7,500.00
+
 Quick View

anti-human

Matuzumab Biosimilar – Research Grade [ICH4007]

$718.00 – $7,500.00
2020 FDA Approvals Evolocumab
+
 Quick View

anti-human

Evolocumab Biosimilar – Research Grade [ICH4023]

$718.00 – $7,500.00